Client
DiaSys Diagnostic Systems GmbH and individual shareholders
DiaSys Diagnostic Systems is a multinational company with headquarter in Holzheim. DiaSys focuses on R&D and sales of in-vitro-diagnostic products and has a good reputation as “Father of Fluid Biochemic Reagent”. It is also the first company in Europe to receive the CE-Certificate of in-vitro-diagnostic reagent.
Project Outline
· Buyer: Beijing Leadman Biochemistry Co., Ltd, founded in November 1997. It is a high-tech enterprise focusing on R & D, manufacture, and sales of in vitro diagnostic (IVD) products. Leadman is listed on the Shenzhen stock exchange on Feb.16th 2014(Ticker: 300289).
· Seller: DiaSys Diagnostic Systems GmbH and individual Shareholders
· Target: DiaSys Diagnostics Systems (Shanghai) Co., Ltd and DiaSys Diagnostics Products (Shanghai) Co., Ltd.，subsidiaries of DiaSys Diagnostic Systems GmbH.
· Our Service: successful support through the whole M&A process as the exclusive M&A adviser of the seller, including market screening for potential investor, design of the transaction structure, company valuation, coordination of the Due Diligence, negotiation with the buyers and banks, consulting and support to contract/document drafting, etc.
· Contract signed on 11 September 2014. Closing (1st step) ended in September 2014
· After closing, assisted the client in the successful exit of the minority shareholder from the JV in 2022
